Arlene O Siefker-Radtke (A O Siefker-Radtke, Arlene Siefker-Radtke)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Metastatic Renal Cell Carcinoma

Ejection Fraction

Top Venues

Cancer immunology, immunotherapy : CII

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Arika S Feils, Amy K Erbe, Jennifer Birstler, KyungMann Kim, U Hoch, S L Currie, T Nguyen, D Yu, Arlene O Siefker-Radtke, Nizar M Tannir, Sara M Tolaney, Adi Diab, Paul M Sondel
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer immunology, immunotherapy : CII (2023)
Arlene O Siefker-Radtke, Diana Cauley, Omar Alhalabi
Combinations, Sequencing, and the Contribution of Components: New Frontline Standards for Metastatic Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, Yang Lu, Qi Wang, Sumankalai Ramachandran, Rebecca S Slack Tidwell, Guangchun Han, Xinmiao Yan, Jieru Meng, Ruiping Wang, Anh G Hoang, Wei-Lien Wang, Jian Song, Lidia Lopez, Alex Andreev-Drakhlin, Arlene O Siefker-Radtke, Xinqiao Zhang, William F Benedict, Amishi Yogesh Shah, Jennifer Wang, Pavlos Msaouel, Miao Zhang, Charles C Guo, Bogdan Czerniak, Carmen Behrens, Luisa Maren Solis Soto, Vassiliki Papadimitrakopoulou, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jiun-Kae Jack Lee, Jack A Roth, Stephen G Swisher, Ignacio Wistuba, John Victor Heymach, Jing Wang, Matthew T Campbell, Eleni Efstathiou, Mark Titus, Christopher L Logothetis, Thai H Ho, Jianjun Zhang, Linghua Wang, Jianjun Gao
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nature communications 13 (1) (2022)
Robert A Huddart, Arlene O Siefker-Radtke, Arjun V Balar, Mehmet A Bilen, Thomas Powles, Aristotelis Bamias, Daniel Castellano, Maged F Khalil, Michiel S Van Der Heijden, Vadim S Koshkin, David W Pook, Mustafa Özgüroğlu, Linda Santiago, Bob Zhong, David Chien, Wei Lin, Mary A Tagliaferri, Yohann Loriot
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer. Future oncology (London, England) 17 (2) (2020)